UNICHEMLAB - Unichem Laboratories Ltd. Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

UNICHEMLAB

82/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹335.70+3.35(+1.01%)

Market Closed as of Apr 10, 2026, 15:30 IST

Select time range

Pros

Profitability: Recent profitability of 13% is a good sign.

Technicals: Bullish SharesGuru indicator.

Balance Sheet: Strong Balance Sheet.

Smart Money: Smart money has been increasing their position in the stock.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Cons

Past Returns: Underperforming stock! In past three years, the stock has provided 1.2% return compared to 10.7% by NIFTY 50.

Momentum: Stock is suffering a negative price momentum. Stock is down -15.2% in last 30 days.

Valuation
Market Cap	2.36 kCr
Price/Earnings (Trailing)	8.02
Price/Sales (Trailing)	1.04
EV/EBITDA	5.5
Price/Free Cashflow	-22.89
MarketCap/EBT	7.13
Enterprise Value	2.66 kCr

Fundamentals
Revenue (TTM)	2.26 kCr
Rev. Growth (Yr)	-2.5%
Earnings (TTM)	294.9 Cr
Earnings Growth (Yr)	356.9%

Profitability
Operating Margin	5%
EBT Margin	15%
Return on Equity	12.11%
Return on Assets	8.29%
Free Cashflow Yield	-4.37%

Growth & Returns
Price Change 1W	-0.10%
Price Change 1M	-15.2%
Price Change 6M	-39.4%
Price Change 1Y	-56.5%
3Y Cumulative Return	1.2%
5Y Cumulative Return	-1%
7Y Cumulative Return	6.3%
10Y Cumulative Return	2.7%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-241.23 Cr
Cash Flow from Operations (TTM)	-7.02 Cr
Cash Flow from Financing (TTM)	183.76 Cr
Cash & Equivalents	178.03 Cr
Free Cash Flow (TTM)	-144.38 Cr
Free Cash Flow/Share (TTM)	-20.51

Balance Sheet
Total Assets	3.56 kCr
Total Liabilities	1.12 kCr
Shareholder Equity	2.43 kCr
Current Assets	2.03 kCr
Current Liabilities	1.02 kCr
Net PPE	1.23 kCr
Inventory	977.9 Cr
Goodwill	1.55 Cr

Capital Structure & Leverage
Debt Ratio	0.13
Debt/Equity	0.19
Interest Coverage	10.98
Interest/Cashflow Ops	0.7

Dividend & Shareholder Returns
Dividend Yield	0.64%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	64.2
RSI (5d)	100
RSI (21d)	52.46
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Sell
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Shareholder Name	Holding %
Ipca Laboratories Limited	52.67%
Dr. Prakash Amrut Mody	12.78%
Hdfc Small Cap Fund	7.75%
Anita Prakash Mody	1.88%
Suparna Prakash Mody	1.35%
Supriya Prakash Mody	1.35%
Dsp Healthcare Fund	1.21%
Dr. Prakash Amrut Mody - Suparna Mody Trust (Promoter Trust )	0.07%
Dr. Prakash Amrut Mody - Shwetambari Mody Trust (Promoter Trust)	0.06%
Dr. Prakash Amrut Mody - Supriya Mody Trust (Promoter Trust)	0.06%
The Hongkong And Shanghai Banking Corp.Ltd.	0%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
SUNPHARMA	Sun Pharmaceutical Industries	3.97 LCr	58.94 kCr	-9.40%	+0.20%	36.37	6.74	-	-
LUPIN	Lupin	1.07 LCr	26.49 kCr	-0.50%	+21.60%	22.94	4.02	-	-
DRREDDY	Dr. Reddy's Lab	1.03 LCr	36.09 kCr	-7.30%	+12.30%	18.38	2.84	-	-
CIPLA	Cipla	99.34 kCr	29.37 kCr	-7.50%	-13.10%	21.84	3.38	-	-
AUROPHARMA	Aurobindo Pharma	78.54 kCr	33.73 kCr	+3.60%	+27.80%	22.52	2.33	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	23.8%	2,111	1,705	1,343	1,270	1,235	1,211
Other Income	9.7%	35	32	39	48	50	91
Total Income	23.6%	2,146	1,736	1,382	1,317	1,285	1,302
Cost of Materials	19.5%	888	743	532	456	467	421
Purchases of stock-in-trade	194544%	176	0.91	1.53	1.35	0.54	1.04
Employee Expense	2.3%	402	393	356	330	307	273
Finance costs	-9.1%	21	23	17	6.11	5.12	7.85
Depreciation and Amortization	10.7%	125	113	113	91	84	82
Other expenses	6%	580	547	481	451	458	601
Total Expenses	14.4%	1,992	1,741	1,519	1,294	1,234	1,351
Profit Before exceptional items and Tax	3143.5%	155	-4.06	-137.8	23	52	-49.02
Exceptional items before tax	98.3%	0	-57.61	-38.57	0	0	0
Total profit before tax	345.7%	155	-61.67	-176.36	23	52	-49.02
Current tax	145%	18	7.94	11	11	17	5.47
Deferred tax	-1471.4%	-1.2	0.86	15	-21.84	-0.15	6.5
Total tax	104.9%	17	8.81	26	-11.09	17	12
Total profit (loss) for period	291.7%	138	-70.47	-202.23	33	34	-60.18
Other comp. income net of taxes	-23.2%	-6.97	-5.47	46	54	16	3.06
Total Comprehensive Income	268.9%	131	-75.95	-156.3	87	51	-57.13
Earnings Per Share, Basic	268.3%	19.53	-10.01	-28.72	4.7	4.88	-8.55
Earnings Per Share, Diluted	267.8%	19.47	-10.01	-28.72	4.68	4.88	-8.55

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	-10%	521	579	527	587	533	462
Other Income	-45%	12	21	6.82	9.25	14	8.79
Total Income	-11.2%	533	600	533	596	547	471
Cost of Materials	-9.9%	174	193	217	275	175	210
Purchases of stock-in-trade	23.1%	49	40	51	33	63	15
Employee Expense	-1%	99	100	107	96	102	99
Finance costs	-11.3%	7.42	8.24	6.54	5.46	6.75	4.79
Depreciation and Amortization	0%	31	31	32	30	31	29
Other expenses	-1.4%	140	142	152	142	154	131
Total Expenses	-6.7%	515	552	542	539	485	438
Profit Before exceptional items and Tax	-63%	18	47	-9.02	58	62	33
Exceptional items before tax	564.1%	276	-58.26	0	0	0	0
Total profit before tax	2570.4%	293	-10.82	-9.02	58	62	33
Current tax	-11550%	-1.33	0.98	1.4	6.4	10	0.01
Deferred tax	3286.8%	30	0.09	0.05	-1.57	-6.45	2.49
Total tax	39900%	29	1.07	1.45	4.83	4	2.5
Total profit (loss) for period	2140.3%	264	-11.89	-10.47	53	58	30
Other comp. income net of taxes	-461.2%	-2.07	1.85	3.05	-6.27	1.86	-2.82
Total Comprehensive Income	2464.1%	262	-10.04	-7.42	47	60	28
Earnings Per Share, Basic	1458.4%	37.54	-1.69	-1.49	7.52	8.22	4.34
Earnings Per Share, Diluted	1455.8%	37.47	-1.69	-1.49	7.5	8.19	4.32

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	20.4%	1,736	1,442	1,072	943	1,124	905
Other Income	37.9%	41	30	42	42	47	99
Total Income	20.7%	1,777	1,473	1,114	985	1,171	1,004
Cost of Materials	15.8%	830	717	500	435	449	400
Purchases of stock-in-trade	-66.7%	0.85	0.91	1.53	1.35	0.54	1.04
Employee Expense	1.8%	288	283	271	251	234	205
Finance costs	-26.4%	7.62	10	9.38	2.07	1.3	1.28
Depreciation and Amortization	2.9%	108	105	106	83	76	71
Other expenses	-4.8%	397	417	371	352	362	408
Total Expenses	6%	1,598	1,507	1,281	1,072	1,106	1,068
Profit Before exceptional items and Tax	600.4%	179	-34.57	-166.43	-86.75	66	-63.81
Exceptional items before tax	105.1%	4	-57.61	-112.66	0	0	0
Total profit before tax	295.3%	183	-92.18	-279.09	-86.75	66	-63.81
Current tax	-	0	0	0	0.24	0.62	0
Deferred tax	-	20	0	21	-31.56	11	-7.5
Total tax	-	20	0	21	-31.32	12	-7.5
Total profit (loss) for period	273.9%	163	-92.18	-299.7	-55.43	54	-56.32
Other comp. income net of taxes	41.2%	0.1	-0.53	39	55	21	3
Total Comprehensive Income	272.9%	163	-92.71	-260.98	-0.06	75	-53.32
Earnings Per Share, Basic	257.2%	23.15	-13.09	-42.57	-7.87	7.68	-8
Earnings Per Share, Diluted	256.7%	23.08	-13.09	-42.57	-7.87	7.68	-8

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	-11.8%	315	357	384	461	448	437
Other Income	-30%	15	21	4.25	6.05	19	7.08
Total Income	-12.7%	330	378	388	467	467	444
Cost of Materials	-7.9%	152	165	204	221	193	216
Purchases of stock-in-trade	-45.3%	0.23	0.47	0.12	0.18	0.18	0.21
Employee Expense	-4.2%	70	73	73	70	73	72
Finance costs	-59%	2.1	3.68	1.93	1.53	2.89	1.82
Depreciation and Amortization	0%	30	30	30	27	28	26
Other expenses	-8.7%	95	104	104	93	104	97
Total Expenses	-9.7%	346	383	390	415	405	401
Profit Before exceptional items and Tax	-193.5%	-15.7	-4.69	-1.87	52	62	43
Exceptional items before tax	905.5%	276	-33.14	0	4	0	0
Total profit before tax	767%	260	-37.83	-1.87	56	62	43
Current tax	-	0	0	0.44	0	0	0
Deferred tax	3809.1%	44	2.1	-0.46	4.81	15	0
Total tax	3809.1%	44	2.1	-0.02	4.81	15	0
Total profit (loss) for period	625.3%	216	-39.93	-1.85	51	47	43
Other comp. income net of taxes	-205.6%	0.45	0.82	3.68	1.41	-1.11	-0.8
Total Comprehensive Income	638.5%	217	-39.11	1.83	53	46	43
Earnings Per Share, Basic	545.1%	30.69	-5.67	-0.26	7.28	6.66	6.16
Earnings Per Share, Diluted	544.4%	30.64	-5.67	-0.26	7.26	6.63	6.15

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	98.9%	178	90	188	151	63	184
Current investments	-	0	0	0	1.34	1.58	1.54
Loans, current	0%	0.06	0.06	0.06	0.04	0.06	0.06
Total current financial assets	7.9%	972	901	829	766	682	777
Inventories	-1.1%	978	989	837	705	638	625
Current tax assets	-	0	0	8.67	0	2.32	0
Total current assets	-0.1%	2,026	2,029	1,823	1,694	1,532	1,588
Property, plant and equipment	-3.8%	1,230	1,279	1,151	1,194	1,225	1,255
Capital work-in-progress	160%	79	31	145	123	122	147
Investment property	-	0	0	0	0	0	0
Goodwill	0%	1.55	1.55	1.55	1.55	1.55	1.55
Non-current investments	0%	0.02	0.02	0.02	0.02	0.02	0.16
Loans, non-current	-3.5%	0.11	0.14	0.11	0.13	0.14	0.13
Total non-current financial assets	6.6%	8.92	8.43	6.22	6.04	6.06	6.6
Total non-current assets	-0.4%	1,525	1,531	1,481	1,472	1,534	1,601
Total assets	-0.4%	3,556	3,569	3,311	3,169	3,070	3,193
Borrowings, non-current	-30%	43	61	25	38	51	64
Total non-current financial liabilities	-22.4%	67	86	51	62	61	75
Provisions, non-current	-2.7%	37	38	39	36	46	42
Total non-current liabilities	-17.5%	105	127	91	99	108	118
Borrowings, current	16.6%	430	369	243	181	225	234
Total current financial liabilities	-3.4%	799	827	654	514	473	575
Provisions, current	31.4%	181	138	141	136	12	12
Current tax liabilities	-116.2%	0.46	4.34	0	2.21	0	0.49
Total current liabilities	2.5%	1,017	992	820	708	554	640
Total liabilities	0.2%	1,121	1,119	910	807	662	758
Equity share capital	0%	14	14	14	14	14	14
Total equity	-0.7%	2,435	2,451	2,401	2,362	2,408	2,435
Total equity and liabilities	-0.4%	3,556	3,569	3,311	3,169	3,070	3,193

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	166.7%	161	61	162	126	51	156
Current investments	-	0	0	0	1.34	1.58	1.54
Loans, current	4.3%	8.94	8.61	0.06	0.04	0.06	0.06
Total current financial assets	-1.5%	837	850	818	689	579	633
Inventories	3.6%	605	584	559	501	481	480
Total current assets	-3.7%	1,508	1,566	1,518	1,406	1,262	1,293
Property, plant and equipment	-3.6%	1,211	1,256	1,125	1,165	1,209	1,236
Capital work-in-progress	160%	79	31	145	122	122	148
Investment property	-	0	0	0	0	0	0
Non-current investments	2.2%	47	46	45	43	40	39
Loans, non-current	6.1%	36	34	0.11	0.13	0.14	0.13
Total non-current financial assets	4.7%	90	86	51	49	46	45
Total non-current assets	1.6%	1,558	1,533	1,473	1,454	1,531	1,590
Total assets	-1.2%	3,071	3,109	2,998	2,864	2,796	2,886
Borrowings, non-current	-30%	43	61	25	38	51	64
Total non-current financial liabilities	-25.4%	54	72	36	44	58	70
Provisions, non-current	-2.7%	37	38	39	36	46	42
Total non-current liabilities	-12.4%	114	130	75	81	105	113
Borrowings, current	-28.6%	36	50	47	26	63	38
Total current financial liabilities	-10.8%	323	362	398	299	279	328
Provisions, current	31.4%	181	138	141	136	12	12
Total current liabilities	2.7%	534	520	563	488	353	389
Total liabilities	-0.2%	648	649	638	569	458	502
Equity share capital	0%	14	14	14	14	14	14
Total equity	-1.5%	2,423	2,460	2,360	2,295	2,337	2,384
Total equity and liabilities	-1.2%	3,071	3,109	2,998	2,864	2,796	2,886

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-9.1%	21	23	17	6.11	-	-
Change in inventories	-215.1%	-252.48	-79.45	-25.01	-61.88	-	-
Depreciation	10.7%	125	113	113	91	-	-
Impairment loss / reversal	-	0	0	3.42	7.47	-	-
Unrealised forex losses/gains	250.5%	4.01	-1	2.66	-7.22	-	-
Share-based payments	-46.2%	2.12	3.08	1.05	2.85	-	-
Net Cashflows from Operations	-52.2%	12	24	-72.36	-235.2	-	-
Dividends received	-	0	0	-0.01	-10.01	-	-
Interest received	-130.5%	-2.85	-0.67	-0.52	-6.48	-	-
Income taxes paid (refund)	178.8%	16	6.38	12	7.62	-	-
Other inflows (outflows) of cash	-	0	0	0	-0.31	-	-
Net Cashflows From Operating Activities	-150.1%	-7.02	17	-85.09	-259.61	-	-
Cashflows used in obtaining control of subsidiaries	-	84	0	0	0	-	-
Proceeds from sales of PPE	-85.3%	2.17	8.94	6.37	0.16	-	-
Purchase of property, plant and equipment	518.2%	137	23	44	127	-	-
Dividends received	-	0	0	0.01	10	-	-
Interest received	260.5%	1.69	0.57	0.94	15	-	-
Other inflows (outflows) of cash	-815.7%	-24.64	-1.8	3.3	0.39	-	-
Net Cashflows From Investing Activities	-594.3%	-241.23	50	203	100	-	-
Proceeds from borrowings	-	235	0	0	239	-	-
Repayments of borrowings	-67.5%	26	78	33	9.52	-	-
Payments of lease liabilities	11.4%	5.9	5.4	3.4	0	-	-
Dividends paid	16.5%	0.34	0.21	28	28	-	-
Interest paid	-9.5%	20	22	16	5.08	-	-
Net Cashflows from Financing Activities	270.5%	184	-106.31	-81.3	191	-	-
Effect of exchange rate on cash eq.	-131.3%	-0.68	6.37	1.75	0	-	-
Net change in cash and cash eq.	-95.5%	-65.17	-32.84	38	32	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-26.4%	7.62	10	9.38	2.07	-	-
Change in inventories	-296.1%	-83.53	-20.34	-19.5	-74.58	-	-
Depreciation	2.9%	108	105	106	83	-	-
Impairment loss / reversal	-	-4	0	94	8.31	-	-
Unrealised forex losses/gains	-216.9%	-1.63	0.17	-1.44	-1.63	-	-
Share-based payments	-	0	0	1.05	2.25	-	-
Net Cashflows from Operations	276.3%	75	-40.98	-116.99	-145.77	-	-
Dividends received	-	0	0	-0.01	-10.01	-	-
Interest received	-154.2%	-2.66	-0.44	-0.24	-6.27	-	-
Income taxes paid (refund)	15.3%	0.28	0.15	0.09	-4.06	-	-
Other inflows (outflows) of cash	-	0	0	0	-0.31	-	-
Net Cashflows From Operating Activities	266.8%	72	-41.57	-117.33	-158.31	-	-
Cashflows used in obtaining control of subsidiaries	-5.9%	0.82	0.83	2.71	2.23	-	-
Proceeds from sales of PPE	-75.6%	2.94	8.94	6.37	0	-	-
Purchase of property, plant and equipment	489.5%	113	20	42	127	-	-
Proceeds from sales of investment property	-	0	0	0	0.16	-	-
Dividends received	-	0	0	0.01	10	-	-
Interest received	174.6%	1.5	0.33	0.67	15	-	-
Other inflows (outflows) of cash	-2258.9%	-24.24	-0.07	3.7	6.29	-	-
Net Cashflows From Investing Activities	-355.9%	-132.07	53	202	104	-	-
Proceeds from borrowings	-	72	0	0.85	135	-	-
Repayments of borrowings	-32.4%	26	38	26	9.52	-	-
Payments of lease liabilities	106%	1.05	0.17	0.15	0	-	-
Dividends paid	19%	0.36	0.21	28	28	-	-
Interest paid	-39.3%	6.25	9.65	8.54	1.57	-	-
Other inflows (outflows) of cash	-	-42.87	0	0	0	-	-
Net Cashflows from Financing Activities	88.6%	-4.61	-48.06	-61.76	96	-	-
Effect of exchange rate on cash eq.	-131.3%	-0.68	6.37	1.75	0	-	-
Net change in cash and cash eq.	-113%	-65.07	-30.02	25	42	-	-

UNICHEMLAB - Unichem Laboratories Ltd. Share Price

UNICHEMLAB

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

UNICHEMLAB

UNICHEMLAB - Unichem Laboratories Ltd. Share Price

UNICHEMLAB

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

UNICHEMLAB

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Unichem Laboratories Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Unichem Laboratories Ltd. do?

Important Disclosure & Data Context